D. Latocha

发表

TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.

Angela G. Fleischman, B. Druker, M. Deininger, 2011, Blood.

Functional assay for human CD4+CD25+ Treg cells reveals an age‐dependent loss of suppressive activity

D. Bourdette, A. Vandenbark, H. Offner, 2003, Journal of neuroscience research.

Aurora A kinase as a target for therapy in TCF3-HLF rearranged acute lymphoblastic leukemia

M. Loh, C. Mullighan, B. Druker, 2021, Haematologica.

Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis.

B. Druker, M. Deininger, A. Agarwal, 2013, Cancer research.

Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells define commitment to apoptosis

B. Druker, M. Deininger, A. Agarwal, 2013 .

Specificity of regulatory CD4+CD25+ T cells for self‐T cell receptor determinants

D. Bourdette, A. Vandenbark, H. Offner, 2004, Journal of neuroscience research.

T‐cell hybridoma specific for myelin oligodendrocyte glycoprotein‐35–55 peptide produced from HLA‐DRB1*1501‐transgenic mice

D. Bourdette, W. Born, A. Vandenbark, 2004, Journal of neuroscience research.

YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway

C. Mullighan, B. Druker, J. Tyner, 2015, Journal of Hematology & Oncology.

CD4 T-cell epitopes of human alpha B-crystallin.

D. Bourdette, A. Vandenbark, S. Subramanian, 2004, Journal of Neuroscience Research.

Self-enforcing Feedback Activation between Bcl6 and Pre-b Cell Receptor Signaling Defines a Distinct Subtype of Acute Lymphoblastic Leukemia Self-enforcing Feedback Activation between Bcl6 and Pre-b Cell Receptor Signaling Defines a Distinct Subtype of Acute Lymphoblastic Leukemia Figure 1. Expressi

M. Loh, A. Melnick, R. Roeder, 2022 .

6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells

A. Yen, J. Varner, R. Bunaciu, 2015, PloS one.

Adrenocorticotropic hormone controls Concanavalin A activation of rat lymphocytes by modulating IL-2 production.

D. Latocha, B. L. Clarke, A. S. Wermerskirchen, 2000, Life sciences.

CD4 T‐cell epitopes of human α B‐crystallin

D. Bourdette, A. Vandenbark, S. Subramanian, 2004 .

BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein.

James M. Roberts, Angela G. Fleischman, S. McWeeney, 2014, Blood.

oncoprotein BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic

James M. Roberts, S. McWeeney, J. Cortes, 2014 .

Concomitant use of a dual ABL/Src kinase inhibitor eliminates the in vitroefficacy of blinatumomab against Ph+ ALL.

B. Druker, J. Tyner, B. Chang, 2020, Blood.

Dynamic and Nuclear Expression of PDGFRα and IGF-1R in Alveolar Rhabdomyosarcoma

C. Rudin, Feimeng Zheng, C. Keller, 2013, Molecular Cancer Research.

Therapeutic vaccination with a trivalent T‐cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis

D. Bourdette, A. Vandenbark, H. Offner, 2008, Immunology.

Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia

Michal R. Grzadkowski, S. McWeeney, R. Ries, 2022, Nature Communications.

Cryptic Intracellular Retention of ABL Tyrosine Kinase Inhibitors within CML Cells Mediates Apoptosis Commitment Following Acute Drug Exposure

B. Druker, M. Deininger, A. Agarwal, 2011 .

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia

Michal R. Grzadkowski, S. McWeeney, R. Ries, 2019, Nature Communications.

Running Title: Nuclear Receptor Tyrosine Kinases in Rhabdomyosarcoma

C. Keller, J. Michalek, A. Wagers, 2013 .

Self‐presentation of beryllium by BAL CD4+ T cells: T cell–T cell interactions and their potential role in chronic beryllium disease

A. Vandenbark, A. Fontenot, D. Mack, 2006, European journal of immunology.